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Exposure to second-hand smoke (also known as environ-
mental tobacco smoke or passive smoke) has been well 
documented to have harmful effects on health, such as lung 
cancer, cardiovascular disease, respiratory disease, asthma 
or low birth weight in children of nonsmoking parents [1]. It 
is estimated that exposure to second-hand smoke is respon-
sible for 1% of mortality worldwide and 47% of these deaths 
occur in women, 28% in children and 26% in men [2]. 
Individual and public health measures are known to be 
effective in decreasing smoking prevalence and its conse-
quences on health. In 2003, the World Health Organization 
adopted the WHO Framework Convention on Tobacco Con-
trol (WHO FCTC) [3]. This treaty contains tobacco control 
measures and directives aimed at decreasing the offer of and 
demand for tobacco products, such as control of price and 
taxes, protection from second-hand smoke, and regulation 
of tobacco product disclosures, packaging and marketing. 
Along with price control, smoking bans are among the most 
effective measures. 
Smoking bans aim to protect the public and employees from 
the harmful effects of second-hand smoke. They also have 
the potential to influence social norms and help smokers 
quit by making smoking less available. A recently updated 
Cochrane review, including 77 studies from 21 countries, 
assessed the effects of legislative smoking bans on morbidi-
ty and mortality from exposure to second-hand smoke, as 
well as on smoking prevalence [4]. The results showed a 
consistent positive impact of national smoking bans on 
cardiovascular health outcomes, in particular on admissions 
for acute coronary syndrome and on mortality from associ-
ated smoking-related illnesses. Effects on respiratory and 
perinatal health, as well on smoking prevalence, were less 
consistent. 
Vicedo-Cabrera and colleagues have published in Swiss 
Medical Weekly a nationwide study assessing the impact on 
cardiorespiratory hospitalisation and mortality of the im-
plementation of smoking bans in Switzerland [5]. They used 
a quasi-experimental design and interrupted time-series 
analyses, taking advantage of the Swiss federalist system. 
On May 2010, a national smoking ban was approved by the 
Swiss parliament. The ban covered indoor public places and 
workplaces, but was not a strict ban in the sense that it 
authorised several exceptions, such as dedicated smoking 
rooms or small smoking establishments. Before the ban was 
enforced, however, many cantons had already introduced 
their own, more or less restrictive smoking bans (the canton 
of Ticino was the first to apply a smoking ban, in 2007). After 
the federal law was enacted some cantons chose to adopt 
stricter bans, whereas some others only applied the less 
restrictive federal law. Therefore, the differential implemen-
tation of the smoking bans in Switzerland is a good oppor-
tunity to assess its effect on health outcomes for each can-
ton separately, at different time points, controlling for 
existing time trends. The results for respiratory mortality 
are unequivocal with an 8.2% decrease in mortality associat-
ed with smoking bans for chronic obstructive pulmonary 
disease (COPD) and a 13.9% decrease for asthma. However, 
no significant changes in mortality for cardiovascular dis-
ease were observed. For hospitalisation, the results are 
disappointing at a first sight, as total rates of hospitalisation 
due to cardiovascular and respiratory diseases did not sig-
nificantly change after the introduction of smoking bans. 
However, if we look closer at the results, the data suggest 
that hospitalisations for ischaemic heart disease decrease by 
2.5% for all adults and 5.5% for the middle-aged group. Re-
garding children’s health, the authors did not observe signif-
icant decrease in infant mortality and hospital admissions 
for respiratory disease after the smoking bans. Analyses also 
suggested that more restrictive bans have a greater effect on 
hospitalisation for ischaemic heart disease, and on hospital-
isation and mortality from COPD than the federal law. 
This study was based on health statistics from the Federal 
Office and only captures emergency hospital admissions, 
missing consultations for chronic diseases or health issues, 
such as asthma in children, not necessarily leading to a 
hospitalisation. Furthermore, it is difficult to measure pre-
cisely the effect of the smoking bans, owing to their progres-
sive implementation in each canton. Finally, smoking bans 
might incompletely reflect exposure to second-hand smoke. 
Indeed, many individuals such as retired people, domestic 
workers or children might be exposed to SHS at home or in 
institutions. Because of these limitations, the analyses 
might underestimate the real impact of smoking bans on 
health. 
The study clearly shows the impact of smoking bans on 
respiratory mortality. However, regarding cardiovascular 
mortality and hospitalisation for cardiopulmonary disease 
the impact of a smoking ban was less significant. So what 
conclusion should we draw? Do methodological issues bias 
the results toward the null or is the Swiss smoke-free legisla-
tion not restrictive enough, which explains why a lesser 
health impact than expected was observed in this study? 
Studies have suggested that comprehensive smoking bans 
have a greater impact on health [4, 6].  Switzerland voted for 
smoking bans with exceptions. Indeed, only 8 of the 26 
cantons have nearly comprehensive smoking bans. In 2012, 
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the Swiss Pulmonary League, with many national activists 
for tobacco control, launched a constitutional initiative 
asking for a simple and comprehensive national indoor 
smoking ban. Unfortunately, 66% of Swiss citizens rejected 
this initiative [7]. If we hypothesise that the initiative had 
passed and that all cantons had implemented restrictive 
smoking bans, we could potentially have a further decrease 
in hospitalisations for acute myocardial infarct, from 2.5% 
(estimate based on this article) to 14% (estimate for places 
with comprehensive smoking bans [8]). This would repre-
sent approximately 2000 additional hospitalisations for 
acute myocardial infarction avoided in Switzerland per year. 
Switzerland has the potential to perform better in the field 
of tobacco control. 
As a reminder, Switzerland is one of the few countries that 
has signed but not ratified the WHO FCTC treaty. At a Euro-
pean level, Switzerland is one of the poorer-performing 
countries the in application of public health policies [9]. It 
ranked 28/34 for smoke-free public places in 2013. And the 
story is about to be repeated. A new law proposal aimed at 
protecting the population from harmful effects of smoking 
(LpTab) includes, among others, measures to strengthen 
legislation on the sales and marketing of tobacco products. 
Even if the proposed law were considered as not compre-
hensive enough according to most national anti-tobacco 
experts, it has been rejected by the federal assembly, who 
asked for a revision of the law. 
Moving toward comprehensive applications of public health 
measures along with easily accessible and affordable help 
for smoking cessation has the potential to decrease further 
tobacco use and its burden on health. Smoking prevalence, 
and morbidity and mortality attributable to smoking are 
still important in Switzerland. There is room for improve-
ment in Swiss tobacco control measures. 
Financial disclosure 
Dr C Clair’s research is supported by a grant from the Swiss National 
Science Foundation (PZ00P3_154732). 
Correspondence:  
Carole Clair, M.D., MSc, PD-MER 
Policlinique Médicale Universitaire 
Rue du Bugnon 44 
CH-1011 Lausanne 
carole.clair[at]hospvd.ch 
References 
1 U.S. Department of Health and Human Services. The Health 
Consequences of Involuntary Exposure to Tobacco Smoke: A Re-
port of the Surgeon General. Altanta, GA: Department of Health 
and Human Services, Centers for Disease Control and Preven-
tion, Coordinating Center for Health Promotion, National Center 
for Chronic Disease Prevention and Health Promotion, Office on 
Smoking and Health, 2006. 
2 Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. 
Worldwide burden of disease from exposure to second-hand 
smoke: a retrospective analysis of data from 192 countries. Lan-
cet. 2011;377(9760):139–46. doi:http://dx.doi.org/10.1016/S0140-
6736(10)61388-8. PubMed 
3 Framework Convention on Tobacco Control [Internet]. The 
World Health Organization. 2003. Available from: 
http://www.who.int/fctc/text_download/en/index.html. 
4 Frazer K, Callinan JE, McHugh J, van Baarsel S, Clarke A, Doherty 
K, et al. Legislative smoking bans for reducing harms from 
secondhand smoke exposure, smoking prevalence and tobacco 
consumption. Cochrane Database Syst Rev. 2016;2:CD005992. 
PubMed 
5 Vicedo-Cabrera AM, Röösli M, Radovanovic D, Grize L, Witassek 
F, Schindler C, et al. Cardiorespiratory hospitalisation and mor-
tality reductions after smoking bans in Switzerland. Swiss Med 
Wkly. 2016;146:w14381. 
6 Tabuchi T, Hoshino T, Nakayama T. Are Partial Workplace Smok-
ing Bans as Effective as Complete Smoking Bans? A National 
Population-Based Study of Smoke-Free Policy Among Japanese 
Employees. Nicotine Tob Res. 2016;18(5):1265–73. 
doi:http://dx.doi.org/10.1093/ntr/ntv115. PubMed 
7 Durham AD, Diethelm P, Cornuz J. Why did Swiss citizens refuse 
a comprehensive second-hand smoke ban? Swiss Med Wkly. 
2014;144:w13983. PubMed 
8 Jones MR, Barnoya J, Stranges S, Losonczy L, Navas-Acien A. 
Cardiovascular Events Following Smoke-Free Legislations: An 
Updated Systematic Review and Meta-Analysis. Curr Environ 
Health Rep. 2014;1(3):239–49. 
doi:http://dx.doi.org/10.1007/s40572-014-0020-1. PubMed 
9 Joossens L, Raw M. The Tobacco Control Scale 2013 in Europe. 
Brussel, Belgium: Association of European Cancer Leagues., 2014. 
 
